Targeting gut microbiota in obesity: Effects of prebiotics and probiotics

Nature Reviews Endocrinology

Volumn 7, Issue 11, 2011, Pages 639-646

  Delzenne, Nathalie M ^a   Neyrinck, Audrey M ^a   Bäckhed, Fredrik ^b   Cani, Patrice D ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOXYLAN; FRUCTAN; GLUCOSE; LIPID; PREBIOTIC AGENT; PROBIOTIC AGENT;

ADIPOSE TISSUE; BACTERIAL COLONIZATION; BACTERIAL METABOLISM; BIFIDOBACTERIUM; CELL METABOLISM; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; HOMEOSTASIS; HOST; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS GASSERI; LEAN BODY WEIGHT; LIVER; NONHUMAN; NUTRIENT; OBESITY; PHYLUM; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANIMALS; GASTROINTESTINAL TRACT; HUMANS; METAGENOME; OBESITY; PREBIOTICS; PROBIOTICS; TREATMENT OUTCOME;

EID: 80054913827     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.126     Document Type: Review

References (83)

1. Reinhardt, C., Reigstad, C. S. & Bäckhed, F. Intestinal microbiota during infancy and its implications for obesity. J. Pediatr. Gastroenterol. Nutr. 48, 249-256 (2009).
2. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
3. Reyes, A. et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466, 334-338 (2010).
4. Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480-484 (2009).
5. Ott, S. J. et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-69v(2004).
6. Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070-11075 (2005). (Pubitemid 41105994)
7. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006). (Pubitemid 46018515)
8. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023 (2006). (Pubitemid 46018512)
9. Furet, J. P. et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59, 3049-3057 (2010).
10. Duncan, S. H. et al. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (Lond.) 32, 1720-1724 (2008).
11. Schwiertz, A. et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18, 190-195 (2010).
12. Ley, R. E. Obesity and the human microbiome. Curr. Opin. Gastroenterol. 26, 5-11 (2010).
13. Greiner, T. & Bäckhed, F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol. Metab. 22, 117-123 (2011).
14. Rawls, J. F., Mahowald, M. A., Ley, R. E. & Gordon, J. I. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127, 423-433 (2006). (Pubitemid 44572375)
15. Kovacs, A. et al. Genotype is a stronger determinant than sex of the mouse gut microbiota. Microb. Ecol. 61, 423-428 (2011).
16. Dominguez-Bello, M. G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107, 11971-11975 (2010).
17. Turnbaugh, P. J., Bäckhed, F., Fulton, L. & Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223 (2008). (Pubitemid 351494716)
18. Hildebrandt, M. A. et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716-1724 (2009).
19. Turnbaugh, P. J. et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 1, 6ra14 (2009).
20. Fleissner, C. K. et al. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104, 919-929 (2010).
21. Roberfroid, M. et al. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 104, S1-S63 (2010).
22. Macfarlane, G. T. & Macfarlane, L. E. Acquisition, evolution and maintenance of the normal gut microbiota. Dig. Dis. 27 (Suppl. 1), 90-98 (2009).
23. Derrien, M. et al. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1, 254-268 (2010).
24. Slack, E. et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325, 617-620 (2009).
25. Wen, L. et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455, 1109-1113 (2008).
26. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
27. Wostmann, B. S., Larkin, C., Moriarty, A. & Bruckner-Kardoss, E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab. Anim. Sci. 33, 46-50 (1983).
28. Samuel, B. S. et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G. protein-coupled receptor, Gpr41. Proc. Natl Acad. Sci. USA 105, 16767-16772 (2008).
29. Dewulf, E. M. et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J. Nutr. Biochem. 22, 712-722 (2011).
30. Bjursell, M. et al. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 300, E211-E220 (2011).
31. Bäckhed, F., Manchester, J. K., Semenkovich, C. F. & Gordon, J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA 104, 979-984 (2007). (Pubitemid 46154722)
32. Rabot, S. et al. Germ-free C57BL/6J mice are resistant to high fat diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 24, 4948-4959 (2010).
33. Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008).
34. Yoshida, K., Shimizugawa, T., Ono, M. & Furukawa, H. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43, 1770-1772 (2002). (Pubitemid 35315796)
35. Mandard, S. et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281, 934-944 (2006).
36. Bäckhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718-15723 (2004). (Pubitemid 39473554)
37. Claus, S. P. et al. Colonization-induced host-gut microbial metabolic interaction. MBio. 2, pii: e00271-10 (2011).
38. Cani, P. D. & Delzenne, N. M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 15, 1546-1558 (2009).
39. Cani, P. D. & Delzenne, N. M. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr. Opin. Pharmacol. 9, 737-743 (2009).
40. Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 (2007). (Pubitemid 47025442)
41. Cani, P. D. et al. Selective increases of bifidobacteria in gut microflora improve high fat diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383 (2007). (Pubitemid 47512397)
42. Erridge, C., Attina, T., Spickett, C. M. & Webb, D. J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86, 1286-1292 (2007). (Pubitemid 350126229)
43. Amar, J. et al. Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 87, 1219-1223 (2008). (Pubitemid 351679761)
44. Creely, S. J. et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292, E740-E747 (2007). (Pubitemid 46411051)
45. Al-Attas, O. S. et al. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc. Diabetol. 8, 20 (2009).
46. Deopurkar, R. et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33, 991-997 (2010).
47. Ghanim, H. et al. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-vin mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32, 2281-2287 (2009).
48. Basu, S. et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 19, 476-482 (2011).
49. Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. Plos ONE 5, e9085 (2010).
50. Ghoshal, S., Witta, J., Zhong, J., de, V. W. & Eckhardt, E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50, 90-97 (2009).
51. Laugerette, F. et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J. Nutr. Biochem. 22, 53-59 (2011).
52. Dixon, A. N. et al. Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance. Int. J. Clin. Pract. 62, 1124-1129 (2008). (Pubitemid 351793604)
53. Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP 2 driven improvement of gut permeability. Gut 58, 1091-110v(2009).
54. Muccioli, G. G. et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 6, 392 (2010).
55. Brun, P. et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G518-G525 (2007).
56. De La Serre, C. B. et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G440-G448 (2010).
57. Maccarrone, M. et al. The endocannabinoid system and its relevance for nutrition. Annu. Rev. Nutr. 30, 423-440 (2010).
58. Brignardello, J. et al. Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment. Pharmacol. Ther. 32, 1307-1314 (2010).
59. Reigstad, C. S., Lunden, G. O., Felin, J. & Bäckhed, F. Regulation of serum amyloid Av(SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. Plos ONE 4, e5842 (2009).
60. Scheja, L. et al. Acute-phase serum amyloid A as a marker of insulin resistance in mice. Exp. Diabetes Res. 2008, 230837 (2008).
61. Kalliomaki, M., Collado, M. C., Salminen, S. & Isolauri, E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 87, 534-538 (2008). (Pubitemid 351364532)
62. Collado, M. C., Isolauri, E., Laitinen, K. & Salminen, S. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am. J. Clin. Nutr. 92, 1023-1030 (2010).
63. Wu, X. et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61, 69-78 (2010).
64. Cani, P. D., Dewever, C. & Delzenne, N. M. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br. J. Nutr. 92, 521-526 (2004). (Pubitemid 40277074)
65. Cani, P. D., Neyrinck, A. M., Maton, N. & Delzenne, N. M. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes. Res. 13, 1000-1007 (2005).
66. Cani, P. D., Hoste, S., Guiot, Y. & Delzenne, N. M. Dietary non-digestible carbohydrates promote l-cell differentiation in the proximal colon of rats. Br. J. Nutr. 98, 32-37 (2007). (Pubitemid 47272144)
67. Cani, P. D. et al. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55, 1484-1490 (2006). (Pubitemid 44195391)
68. Cani, P. D. et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90, 1236-1243 (2009).
69. Cani, P. D., Joly, E., Horsmans, Y. & Delzenne, N. M. Oligofructose promotes satiety in healthy human: a pilot study. Eur. J. Clin. Nutr. 60, 567-572 (2006). (Pubitemid 43922875)
70. Aronsson, L. et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). Plos ONE 5, (2010).
71. Ehrlich, S. D. Probiotics-little evidence for a link to obesity. Nat. Rev. Microbiol. 7, 901 (2009).
72. Delzenne, N. & Reid, G. No causal link between obesity and probiotics. Nat. Rev. Microbiol. 7, 901 (2009).
73. Raoult, D. Human microbiome: take-home lesson on growth promoters? Nature 454, 690-691 (2008).
74. Stsepetova, J. et al. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br. J. Nutr. 105, 1235-1244 (2011).
75. Andreasen, A. S. et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr. 104, 1831-1838 (2010).
76. Kadooka, Y. et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin. Nutr. 64, 636-643 (2010).
77. Lu, Z. X., Walker, K. Z., Muir, J. G. & O'Dea, K. Arabinoxylan fibre improves metabolic control in people with type II diabetes. Eur. J. Clin. Nutr. 58, 621-628 (2004). (Pubitemid 38500132)
78. Garcia, A. L. et al. Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance. Horm. Metab. Res. 38, 761-766 (2006). (Pubitemid 44885430)
79. Garcia, A. L. et al. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. Eur. J. Clin. Nutr. 61, 334-341 (2007). (Pubitemid 46358772)
80. Parnell, J. A. & Reimer, R. A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89, 1751-1759 (2009).
81. Luo, J. et al. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J. Nutr. 130, 1572-1577 (2000).
82. Daubioul, C. A., Horsmans, Y., Lambert, P., Danse, E. & Delzenne, N. M. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur. J. Clin. Nutr. 59, 723-726 (2005). (Pubitemid 40716140)
83. Neyrinck, A. M. & Delzenne, N. M. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders. Curr. Opin. Clin. Nutr. Metab. Care 13, 722-728 (2010).